Express News | Cantor Fitzgerald Reiterates Neutral on Amedisys, Maintains $101 Price Target
BenzingaApr 25 10:17 ET
Analysts Offer Insights on Healthcare Companies: Amedisys (AMED) and Gilead Sciences (GILD)
TipRanksApr 25 08:21 ET
Truist Financial Reaffirms Their Hold Rating on Amedisys (AMED)
TipRanksApr 25 07:10 ET
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Yahoo FinanceApr 24 21:00 ET
Amedisys Inc Releases First-Quarter Supplemental Slides
TipRanksApr 24 17:03 ET
Express News | Amedisys Inc Q1 Shr View $1.02 -- Lseg Ibes Data
Moomoo 24/7Apr 24 16:47 ET
Express News | Amedisys Inc: Qtrly Adj Shr $1.03
Moomoo 24/7Apr 24 16:46 ET
Express News | Amedisys Inc: Qtrly Shr $0.44
Moomoo 24/7Apr 24 16:46 ET
Express News | Amedisys Q1 Adjusted Ebitda USD 59.9 Million Vs. Ibes Estimate USD 57.8 Million
Moomoo 24/7Apr 24 16:45 ET
Express News | Amedisys Q1 Net Income USD 14.4 Million
Moomoo 24/7Apr 24 16:45 ET
Express News | Amedisys Reports First Quarter 2024 Financial Results
Moomoo 24/7Apr 24 16:45 ET
Express News | Amedisys Q1 Adjusted Net Income USD 33.9 Million Vs. Ibes Estimate USD 33.8 Million
Moomoo 24/7Apr 24 16:45 ET
Amedisys 1Q Rev $571.4M >AMED
Amedisys 1Q Rev $571.4M >AMED
Dow JonesApr 24 16:45 ET
Amedisys 1Q Adj EPS $1.03 >AMED
Amedisys 1Q Adj EPS $1.03 >AMED
Dow JonesApr 24 16:45 ET
Amedisys Is Maintained at Market Perform by Raymond James
Amedisys Is Maintained at Market Perform by Raymond James
Dow JonesMar 26 13:31 ET
Express News | Raymond James Maintains Market Perform on Amedisysto Market Perform
Moomoo 24/7Mar 26 13:21 ET
Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says
Amedisys' (AMED) acquisition by UnitedHealth Group's (UNH) Optum unit is expected to be completed despite unconfirmed reports of a possible antitrust investigation by the US Department of Justice, RBC Capital Markets said in a note Monday.
MT NewswiresMar 25 12:55 ET
Why Amedisys (AMED) Is a Top Value Stock for the Long-Term
Yahoo FinanceMar 25 09:40 ET
Amedisys Is Maintained at Outperform by RBC Capital
Amedisys Is Maintained at Outperform by RBC Capital
Dow JonesMar 25 08:17 ET
Amedisys Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/25/2024 8.52% RBC Capital $97 → $100 Maintains Outperform 09/14/2023 9.6% Cantor Fitzgerald $100 → $101
BenzingaMar 25 08:05 ET
No Data
No Data